48-week outcomes following switch from AZT/3TC to FTC/TDF (TVD) vs. continuing on AZT/3TC: 48-week interim analysis of the RECOMB trial
| Image |  |
|---|---|
| Description | scholarly article by E Ribera et al published 2008 in Journal of the International AIDS Society |
| Author/s | |
| Publication date | 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |